Cargando…
The Impact of ESBLs-Positive Escherichia coli’s Resistance to Cefepime and Its Guidance for Clinical Treatment
BACKGROUND: Escherichia coli (E. coli) is a common pathogen in bloodstream infections (BSI), and the production of extended-spectrum beta-lactamases (ESBLs) is its main mechanism of resistance. However, the impact of different ESBL genotypes of E. coli on the resistance to Cefepime (FEP) remains unc...
Autores principales: | Wu, Qian, Shi, Jing, Huang, Juan, Gan, Delu, Zhang, Lijun, Li, Pu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544110/ https://www.ncbi.nlm.nih.gov/pubmed/37789844 http://dx.doi.org/10.2147/IDR.S427836 |
Ejemplares similares
-
1228. Outcomes Associated with Empiric Cefepime or Meropenem for Bloodstream Infections Caused by Ceftriaxone-Resistant, Cefepime-Susceptible Escherichia coli and Klebsiella pneumoniae
por: Frescas, Brian E, et al.
Publicado: (2021) -
In vitro activity of cefepime/zidebactam and cefepime/taniborbactam against aztreonam/avibactam-resistant NDM-like-producing Escherichia coli clinical isolates
por: Le Terrier, Christophe, et al.
Publicado: (2023) -
Prevalence of Cefepime-Resistant Escherichia coli in Iran: A Meta-Analysis (2007–2016)
por: BECHASHK, Seyyede Maryam, et al.
Publicado: (2019) -
Clonal Relationship and Resistance Profiles Among ESBL-Producing Escherichia coli
por: Dolatyar Dehkharghani, Alireza, et al.
Publicado: (2021) -
Cefmetazole Resistance Mechanism for Escherichia Coli Including ESBL-Producing Strains
por: Ito, Ryota, et al.
Publicado: (2022)